Modeling the Burden of Cardiovascular Diseases in Iran from 2005 to 2025: The Impact of Demographic Changes
,
Abstract
Background: Estimating the burden of non-communicable diseases particularly cardiovascular disease (CVD) is essential for health management and policymaking. In this paper, we used a regression model to estimate the future impact of demographic changes on the burden of CVD in Iran during the next two decades.
Methods: Disability-adjusted life years (DALY) were used to estimate the future burden of CVD in Iran. A regression model was used to estimate DALY caused by CVD in the Iranian population aged 30–100 yr, stratified by age group and sex. The predicted population of Iranians aged ≥ 30 yr was entered into the model and DALY were calculated over 2005-2025. To assess the areas of uncertainty in the model, we did sensitivity analysis and Monte Carlo Simulation.
Results: In the year 2005, there were 847309 DALYs caused by CVD in Iranian adults aged ≥ 30 yr. This figure will nearly be 1728836 DALYs in 2025. In other words, just because of the aging, DALY related to CVD will increase more than two-fold in 2025 compared with 2005. The burden of CVD was higher in men (443235) than in women (404235) in 2005; but in 2025, the difference will be less (867639 vs. 861319).
Conclusion: The burden of CVD will increase steeply in Iran over 2005–2025, mainly because of the aging population. Therefore, more attention is needed to deal with the impact of CVD in the following decades in Iran.
AD, Colin D Mathers CD, Ezzati M, Jamison DT, Murray CJL (2006). Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet, 367:1747-57.
Lopez AD, Mathers CD (2006). Measuring the global burden of disease and epidemiological transitions: 2002–2030. Ann Trop Med Parasitol, 100:481–99.
Cecchini M, Sassi F, Lauer JA, Lee YY, Guajardo-BarronV, Chisholm D (2010). Tackling of unhealthy diets, physical inactivity, and obesity: health effects and cost-effectiveness. Lancet, 376:1775-1784.
Miranda JJ, Kinra S, Casas JP, Smith GD, Ebrahim S (2008). Non-communicable diseases in low- and middle-income countries: context, determinants and health policy. Trop Med Int Health, 13:1225–34.
Daar A.S, Singer P.A, Persad DL, et al (2007). Grand challenges in chronic non-communicable diseases. Nature, 450:494-496.
Gaziano TA, Bitton A, Anand S, Gessel SA, Murphy A (2010). Growing Epidemic of Coronary Heart Dsease in Low-and Middle income Countries. Curr Probl Cardiol, 35:72-115.
World Health Organization, World Heart Federation, World Stroke Organization (2012). Global atlas on cardiovascular disease prevention and control: policies, strategies, and interventions. Published 2011.
http://www.who.int/cardiovascular_diseases/publications/atlas_cvd/en/. Accessed August 7.
Mathers CD, Loncar D (2005). Updated projections of global mortality and burden of disease, 2002-2030: Data sources, methods and results. Evidence and information for policy. Geneva: World Health Organization.
Heidenreich PA, Trogdon JG, Khavjou OA, Butler J, Dracup K, Ezekowitz MD, et al. (2011) Forecasting the Future of Cardiovascular Disease in the United States: A Policy Statement from the American Heart Association. Circulation, 123:933-944.
Moran A, Gu D, Zhao D, et al. (2010). Future Cardiovascular Disease in China: Markov Model and Risk Factor Scenario Projections from the Coronary Heart Diseas Policy Model China. Circ Cardiovasc Qual Outcomes, 3:243–252.
Mathers CD & Loncar D (2006). Projection of Global mortality and burden of disease from 2002 to 2030. PLos Med, 3(11):e442.
Joshi R, Jan S, Wu Y, MacMahon S (2008). Global Inequalities in Access to Cardiovascular Health Care: Our Greatest Challenge. J Am Coll Cardiol, 52:1817-1825.
Ford ES, Capewell S (2007). Coronary heart disease mortality among young adults in the US from 1980 through 2002: concealed levelling of mortality rates. J Am Coll Cardiol, 50:2128-32.
Gaziano TA (2007). Reducing the Growing Burden of Cardiovascular Disease in the Developing World. Health Aff (Millwood), 26:13-24.
Walls HL, Peeters A, Reid CM, Liew D, McNeil JJ (2008). Predicting the Effectiveness of Prevention: A Role for Epidemiological Modeling. J Prim Prev, 29:295-305.
Geneau R, Stuckler D, Stachenco S, et al. (2010). Raising the priority of preventing chronic diseases: a political process. Lancet, 376:1689–98.
Abegunde D O, Mathers C D, Taghreed A, Ortegon M, Stong K (2007). The burden and costs of chronic diseases in low-income and middle-income countries. Lancet, 370:1929-38.
Strong KL, Mathers CD, Leeder S, Beaglehole R (2005). Preventing chronic diseases: how many lives can we save? Lancet, 366:1578-1582.
Gersh BJ, Sliwa K, Mayosi BM, Yusuf S (2010). Novel therapeutic concepts: the epidemic of cardiovascular disease in the developing world: global implications. Eur Heart J, 31:642-648.
Yusuf S, Hawken S, Ounpuu S, et al. (2004). Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet, 364:937-52.
Capewell S, Ford ES, Croft JB, Critchley JA, Greenlund KJ, Labarthe DR (2010). Cardiovascular risk factor trends in the US population and options for reducing future CHD mortality. Bull World Health Organ, 88:120-30.
Maziak W, Critchley J, Zaman S, et al. (2012). Mediterranean studies of cardiovascular disease and hyperglycemia: analytical modeling of population socioeconomic transitions (Med CHAMPS)-rationale and methods. Int J Public Health, 54:547-53.
Kiani S, Bayanzadeh M, Tavallaee M, Hong RS (2010). The Iranian Population is Graying: Are we ready? Arch Iran Med, 13:333-339.
Sheykhi MT (2006). General review of sociological challenge and prospects of population in Iran a sociological study of quality of life. J Soc Sci, 12:21-32.
Naghavi M, Abolhassani F, Pourmalek F, et al. (2009). The burden of disease and injury in Iran 2003. Popul Health Metr, 7:9.
Fakhrzadeh H, Bandarian F, Adibi H, Samavat T, Malekafzali H, Hodjatzadeh E, Larijani B (2008). Coronary heart disease and associated risk factors in Qazvin; a population–based study. East Mediterr Health J, 14:33–41.
Naghavi M (2002). Features of death in 18 province of Iran in 2000. Tehran, Tandis Publications.
Forouzanfar MH, Sepanlou SG, Shahraz S, et al. (2014). Evaluating causes of death and morbidity in Iran, global burden of diseases, injuries, and risk factors study 2010. Arch Iran Med, 17:304-320.
Hatmi ZN, Tahvildari S, Gafarzadeh Motlagh A, Sabouri Kashani A (2007). Prevalence of coronary artery disease risk factors in Iran: a population based survey. BMC Cardiovasc Disord, 7:32.
Hosseini-Esfahani F, Mousavi Nasl Khameneh A, Mirmiran P, Ghanbarian A, Azizi F (2011). Trends in Risk Factors for Cardiovascular Disease Among Iranian Adolescents: The Tehran Lipid and Glucose Study, 1999–2008. J Epidemiol, 21:319-328.
Saka O, McGuire A, Wolfe C (2009). Cost of stroke in the United Kingdom. Age Aging, 38:27-32.
Homer J, Milstein B, Wile K, Pratibhu P, Farris R, Orenstein D (2008). Modelling the Local Dynamics of Cardiovascular Health; Risk Factors, Context, and Capacity. Prev Chronic Dis, 5:2: A63.
Huovinen E, Hakanen T, Martelin T, Koskinen, Aromaa A (2006). Predicting coronary heart disease mortality – assessing uncertainties in population forecasts and. Int J Epidemiol, 35:1246-1252.
International Database, World Population Prospects. 2015 revision [http://esa.un.org/wpp/population-pyramids/population-pyramids.htm].
Foorouzanfar MH, Spanlou SG, Shahraz S, et al (2014). Evaluating Causes of Death and Morbidity in Iran, Global Burden of Diseases, Injuries, and Risk Factors Study 2010. Arch Iran Med, 17(5):304–320.
Saadat S, Yousefifard M, Asady H, Moghadas Jafari A, Fayaz M, Hosseini M (2015). The most important causes of death in Iranian Population: a retrospective cohort study. Emergency, 3(1):16-21.
Abadi AL, Mohammad K, Aslami F, Alavi Majd H, Behnampour N (2009). Estimation of crude death rate with application of capture-recapture methods. Payesh, 8;11-16. [In Persian]
Taghaddosi I, Kazemnejad A, Sanjari N, Faghizadeh S, Abadi A (2004). A sample coverage approach for estimating the size of the population with application to death undercount. Koomesh, 5:37-44. [In Persian]
Maziak W, Rastam S, Mzayek F, Ward KD, Eissenberg T, Keil (2007). Cardiovascular health among adults in Syria: a model from developing countries. Ann Epidemiol, 17:713–720.
Bandosz P, Flaherty MO, Drygas W, et al. (2012). Decline in mortality from coronary heart disease in Poland after socioeconomic transformation: modeling study. BMJ, 344:1-10.
Odden MC, Coxson PG, Moran A, Lightwood JM, Goldman L, Bibbins-Domingo K (2011). The Impact of Aging Population on Coronary Heart Disease in the United States. Am J Med, 124:827-833.
Struijis JN, Genugten MLL, Evers SMAA, Ament AJHA, Baan CA, Van den Bos GAM (2005). Modeling the Future Burden of Stroke in the Netherlands: Impact of Aging, Smoking, and Hypertension. Stroke, 36:1648-55.
Azami-Aghadash S, Ghafari S, Sadeghi-Bazargani H, Tabrizi JS, Yagoubi A, Naghavi-Behzad M (2013). Developing Indicators of Service Quality Provided for Cardiovascular Patients Hospitalized in Cardiac Care Unit. J Cardiovasc Thorac Res, 5:23-28.
Hosseini SK, Soleimani A, Salarifar M, Pour-hosein H, Nematipoor E, Abbasi SH, Abbasi A (2011). Demographics and Angiographic Findings in Patients under 35 Years of Age with Acute ST Elevation Myocardial Infarction. J Tehran Heart Cent, 6:62-7.
Talaei M, Sarrafzadegan N, Sadeghi M, Oveisgharan S, Marshal T, Thomas N, Iranpour R (2013). Incidence of Cardiovascular Diseases in an Iranian Population: The Isfahan Cohort Study. Arch Iran Med, 16:138–144.
Gaziano TA, Young CR, Fitzmaurice G, At-wood S, Gaziano JM (2008). Laboratory-based versus non-laboratory-based method for assessment of cardiovascular disease risk: the NHANES I Follow-up Study cohort. Lancet, 371:923–931.
Lindholm LH, Mendis S (2007). Prevention of cardiovascular disease in developing countries. Lancet, 370:720–72
| Files | ||
| Issue | Vol 46 No 4 (2017) | |
| Section | Original Article(s) | |
| Keywords | ||
| Cardiovascular diseases Iran Demographic changes DALY Modelling | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
